Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Mishra PK, Mishra H, Ekielski A, Talegaonkar S, Vaidya B
Structure Therapeutics: GSBR-1290 [60] [61] [60] [61] An oral GLP1R agonist, currently being studied in a double-blinded, placebo-controlled Phase 2a clinical trial
Bersoux S, Byun TH, Chaliki SS, Poole KG
Consider Dose Reduction: The 9mg dose has 8.8% dysesthesia vs 12.520.9% at 12mg (depending on trial population)
EllieMD did not respond to TINA.orgs request for comment
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
